Literature DB >> 24361397

High incidence of multiple antibiotic resistant cells in cultures of in enterohemorrhagic Escherichia coli O157:H7.

Benjamin R Carone1, Tao Xu1, Kenan C Murphy2, Martin G Marinus3.   

Abstract

The spontaneous incidence of chloramphenicol (Cam) resistant mutant bacteria is at least ten-fold higher in cultures of enterohemorrhagic Escherichia coli O157:H7 strain EDL933 than in E. coli K-12. It is at least 100-fold higher in the dam (DNA adenine methyltransferase) derivative of EDL933, compared to the dam strain of E. coli K-12, thereby preventing the use of Cam resistance as a marker in gene replacement technology. Genome sequencing of Cam-resistant isolates of EDL933 and its dam derivatives showed that the marR (multiple antibiotic resistance) gene was mutated in every case but not in the Cam-sensitive parental strains. As expected from mutation in the marR gene, the Cam-resistant bacteria were also found to be resistant to tetracycline and nalidixic acid. The marR gene in strain EDL933 is annotated as a shorter open reading frame than that in E. coli K-12 but the longer marR(+) open reading frame was more efficient at complementing the marR antibiotic-resistance phenotype of strain EDL933. Beta-lactamase-tolerant derivatives were present at frequencies 10-100 times greater in cultures of marR derivatives of strain EDL933 than the parent strain. Spontaneous mutation frequency to rifampicin, spectinomycin and streptomycin resistance was the same in E. coli O157:H7 and E. coli K-12 strains.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA; Escherichia coli O157; Genes; Multiple antibiotic resistance; Mutation; Repressor protein

Mesh:

Substances:

Year:  2013        PMID: 24361397      PMCID: PMC3913999          DOI: 10.1016/j.mrfmmm.2013.11.008

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  50 in total

Review 1.  Pathogenesis and evolution of virulence in enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  M S Donnenberg; T S Whittam
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli.

Authors:  H Hächler; S P Cohen; S B Levy
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

3.  Autoactivation of the marRAB multiple antibiotic resistance operon by the MarA transcriptional activator in Escherichia coli.

Authors:  R G Martin; K W Jair; R E Wolf; J L Rosner
Journal:  J Bacteriol       Date:  1996-04       Impact factor: 3.490

4.  Dominant negative mutator mutations in the mutL gene of Escherichia coli.

Authors:  A Aronshtam; M G Marinus
Journal:  Nucleic Acids Res       Date:  1996-07-01       Impact factor: 16.971

5.  H-NS regulates OmpF expression through micF antisense RNA in Escherichia coli.

Authors:  T Suzuki; C Ueguchi; T Mizuno
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

6.  Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter.

Authors:  L M Guzman; D Belin; M J Carson; J Beckwith
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

7.  Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli.

Authors:  A S Seoane; S B Levy
Journal:  J Bacteriol       Date:  1995-06       Impact factor: 3.490

8.  AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants.

Authors:  H Okusu; D Ma; H Nikaido
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

9.  Dominant negative mutator mutations in the mutS gene of Escherichia coli.

Authors:  T H Wu; M G Marinus
Journal:  J Bacteriol       Date:  1994-09       Impact factor: 3.490

10.  Binding of purified multiple antibiotic-resistance repressor protein (MarR) to mar operator sequences.

Authors:  R G Martin; J L Rosner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

View more
  7 in total

1.  Microbial Acoustical Analyzer for Antibiotic Indication.

Authors:  Boris Zaitsev; Irina Borodina; Ali Alsowaidi; Olga Karavaeva; Andrey Teplykh; Olga Guliy
Journal:  Sensors (Basel)       Date:  2022-04-12       Impact factor: 3.847

2.  Epidemiologic and molecular characterization of β-lactamase-producing multidrug-resistant uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients.

Authors:  Arunita Ghosh; Biplab Ghosh; Mandira Mukherjee
Journal:  Int Microbiol       Date:  2021-06-30       Impact factor: 2.479

3.  Novel approach of using a cocktail of designed bacteriophages against gut pathogenic E. coli for bacterial load biocontrol.

Authors:  Ahmed Sahib Abdulamir; Sabah A A Jassim; Fatimah Abu Bakar
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-07-26       Impact factor: 3.944

4.  Effect of β-lactam antibiotic resistance gene expression on the radio-resistance profile of E. coli O157:H7.

Authors:  Ghizlane Gaougaou; Yosra Ben-Fadhel; Eric Déziel; Monique Lacroix
Journal:  Heliyon       Date:  2018-12-01

Review 5.  Bird feathers as potential sources of pathogenic microorganisms: a new look at old diseases.

Authors:  Andrzej Miskiewicz; Paweł Kowalczyk; Sanaa Mahdi Oraibi; Krystyna Cybulska; Anna Misiewicz
Journal:  Antonie Van Leeuwenhoek       Date:  2018-02-19       Impact factor: 2.271

Review 6.  Insights into Emergence of Antibiotic Resistance in Acid-Adapted Enterohaemorrhagic Escherichia coli.

Authors:  Salma Waheed Sheikh; Ahmad Ali; Asma Ahsan; Sidra Shakoor; Fei Shang; Ting Xue
Journal:  Antibiotics (Basel)       Date:  2021-05-02

7.  Synbiotic-like effect of linoleic acid overproducing Lactobacillus casei with berry phenolic extracts against pathogenesis of enterohemorrhagic Escherichia coli.

Authors:  Zajeba Tabashsum; Mengfei Peng; Cassendra Bernhardt; Puja Patel; Michael Carrion; Debabrata Biswas
Journal:  Gut Pathog       Date:  2019-07-27       Impact factor: 4.181

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.